Nutanix, Inc.
For the period ended Jul 31, 2025. Filed Sep 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 24, 2025
NTNX$59.49+1.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| As of | ||
|---|---|---|
| July 31,2024 | July 31,2025 | |
| (in thousands, except per share data) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $655,270 | $769,502 |
| Short-term investments | 339,072 | 1,223,234 |
| Accounts receivable, net of allowances of $772 and $2,187, respectively | 229,796 | 337,967 |
| Deferred commissions—current | 159,849 | 153,072 |
| Prepaid expenses and other current assets | 97,307 | 105,391 |
| Total current assets | 1,481,294 | 2,589,166 |
| Property and equipment, net | 136,180 | 142,814 |
| Operating lease right-of-use assets | 109,133 | 134,526 |
| Deferred commissions—non-current | 198,962 | 189,221 |
| Intangible assets, net | 5,153 | 2,615 |
| Goodwill | 185,235 | 185,235 |
| Other assets—non-current | 27,961 | 39,617 |
| Total assets | $2,143,918 | $3,283,194 |
| Liabilities and Stockholders’ Deficit | ||
| Current liabilities: | ||
| Accounts payable | $45,066 | $81,599 |
| Accrued compensation and benefits | 195,602 | 230,498 |
| Accrued expenses and other current liabilities | 24,967 | 24,187 |
| Deferred revenue—current | 954,543 | 1,054,023 |
| Operating lease liabilities—current | 24,163 | 23,234 |
| Total current liabilities | 1,244,341 | 1,413,541 |
| Deferred revenue—non-current | 918,163 | 1,058,731 |
| Operating lease liabilities—non-current | 90,359 | 115,754 |
| Convertible senior notes, net | 570,073 | 1,343,818 |
| Other liabilities—non-current | 49,130 | 45,870 |
| Total liabilities | 2,872,066 | 3,977,714 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ deficit: | ||
| Common stock, par value of $0.000025 per share—1,000,000 Class A shares authorized as of July 31, 2024 and July 31, 2025; 265,181 and 269,045 Class A shares issued and outstanding as of July 31, 2024 and July 31, 2025, respectively | 7 | 7 |
| Additional paid-in capital | 4,118,898 | 4,200,466 |
| Accumulated other comprehensive income | 146 | 700 |
| Accumulated deficit | (4,847,199) | (4,895,693) |
| Total stockholders’ deficit | (728,148) | (694,520) |
| Total liabilities and stockholders’ deficit | $2,143,918 | $3,283,194 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.